A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
Status:
Recruiting
Trial end date:
2024-08-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if lower doses of radiation may help reduce the side
effects of radiation therapy in combination with standard-of-care chemotherapy in people with
HPV-positive throat cancer. The chemotherapy drugs used in this study include cisplatin,
carboplatin, and 5-fluorouracil (5- FU).